Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

Ablynx is looking for new partners to take its rheumatoid arthritis drug vobarilizumab into phase 3 development, after AbbVie turned down an option to license the drug. AbbVie has already paid the ...

I started typing what mimics rheumatoid arthritis and it popped up saying "you may have Hashimoto's disease, ask your doctor to check your thyroid peroxidase antibody (TPO) levels." 'So I went to ...

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the Inflation Reduction Act... Trump signs executive action to lower drug ...

The global rheumatoid arthritis drugs market is expected to reach $53.1 billion by 2031. The hope is that the IRAK4 degrader GS-6791 is going to be able to help treat these patients in an ...

It is also good to hear about the safety profile of these new oral GLP-1 RA drugs — especially the liver results — and it will be good to see the data in a full publication in due course.” ...